US loss of exclusivity · Vaccines
Shingrix
GSK
2029
US follow-on vaccines from
2025
Today: 2026
2037
2025 worldwide sales
≈$4.8B
Date basis
Patent-expiry estimate
US follow-on vaccines
No US filing found
Pharma Patent Cliff
by readouts.io
Data checked 8 October 2026 ·
Full Shingrix timeline →